Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- Business practices2
- Assessing user fees under the Generic Drug User Fee Amendments of 20171
- Congreso Internacional de Derecho y Economia Farmaceutica1
- Drug manufacturing: FDA should fully assess its efforts to encourage innovation : report to congressional committees1
- Drug safety: preliminary findings indicate persistent challenges with FDA foreign inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives1
- Investigating out-of specification (OOS) test results for pharmaceutical production1
- Opioid crisis1
- Some manufacturers reported inaccurate drug product data to CMS1
- Survey brief: drug companies reduce patients’ access to care by limiting 340B community pharmacies1